KKR forms Falcon Vision to target ophthalmic medical device, biopharma cos

KKR said Feb. 26 that it has formed Falcon Vision, a new platform that will source, evaluate, and provide operational and financial capabilities to emerging ophthalmic medical device and biopharmaceutical companies. Falcon Vision will collaborate with Flying L Partners to manage the portfolio under the leadership of Dr. Bill Link.

DealsNorth AmericaUSHealthcareBriefs